Volume 8, Issue 1 (6-2021)
vacres 2021, 8(1): 88-91 |
Back to browse issues page
Arda Kiani 
, Atefeh Abedini , Zahra Sadat Rouhani , Mohammadhossein Banitorfi , Amirhossein Saeidi , Hamidreza Zaheri *
, Atefeh Abedini , Zahra Sadat Rouhani , Mohammadhossein Banitorfi , Amirhossein Saeidi , Hamidreza Zaheri *
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract: (1378 Views)
Recently the term vaccine-induced immune thrombotic thrombocytopenia (VITT) used for individual which have thrombotic phenomena followed by ChAdOx1 nCoV-19 vaccine (AstraZeneca) administration against SARS coronavirus. Here we report the 27 years old healthy male and known case of G6PD deficiency which come to emergency department with progressive right calf swallow from 12 days ago and hemoptysis from a day ago. he mentioned he had administrated First dose of AstraZeneca vaccine for 3 weeks ago. He admitted with suspected pulmonary thromboembolism (PTE) followed by Deep vein thrombosis (DVT). In color Doppler study there are dilation in right calf vain with elevated lab measurement d-dimer indicated DVT also in computed tomography angiography (CTA) there are some evidence of filling defect in left pulmonary branch and right inferior lobar artery which represent to PTE.
Type of Study: case report |
Subject:
Vaccine development, efficacy and safety evaluation
Received: 2022/01/4
Received: 2022/01/4
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |